ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
IceCure Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026
$1.08+0.02 (+1.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 4.5
- Dividend yield
- –
IceCure Medical statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Market Cap | $78.97M | $230.55M |
| Enterprise Value | $70.09M | $202.97M |
| PE Ratio | 4.50 | 33.40 |
| PS Ratio | 23.37 | 3.11 |
| PB Ratio | 8.73 | 3.14 |
| P/TBV Ratio | 8.73 | 4.57 |
Enterprise value
| Measure | IceCure Medical | Industry median |
|---|---|---|
| EV / Sales | 20.74 | 2.92 |
Income (trailing twelve months)
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Revenue | $3.38M | $102.39M |
| Gross Profit | $1.23M | $60.36M |
| Operating Income | -$15.09M | -$4.31M |
| Net Income | -$15.06M | -$6.57M |
| EBITDA | -$15.09M | -$1.98M |
| EPS (Diluted) | $0.24 | -$0.07 |
Margins
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Gross Margin | 36.3% | 55.1% |
| Operating Margin | -446.7% | -6.04% |
| Profit Margin | -445.6% | -10.5% |
| EBITDA Margin | -446.7% | -2.67% |
| FCF Margin | -432.4% | -0.30% |
Returns
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -188.8% | -19.2% |
| Return on Assets (ROA) | -113.8% | -13.3% |
| Return on Capital Employed (ROCE) | -166.5% | -9.07% |
Growth
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 2.67% | 8.85% |
| EPS Growth (YoY) | -20.0% | 10.6% |
| Revenue Growth (3Y CAGR) | 3.08% | 7.08% |
| Revenue Growth (5Y CAGR) | -2.67% | 11.8% |
| EPS Growth (3Y CAGR) | -19.5% | 3.06% |
| EPS Growth (5Y CAGR) | 1.76% | 7.64% |
Balance sheet
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.90M | $37.33M |
| Total Debt | $13.00K | $72.66M |
| Net Cash (Debt) | $8.88M | $3.92M |
| Net Cash Per Share | $0.12 | $0.28 |
| Equity (Book Value) | $9.05M | $57.36M |
| Book Value Per Share | $0.12 | $2.81 |
| Tangible Book Value | $9.05M | $10.71M |
| Working Capital | $7.78M | $54.64M |
Financial position
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Current Ratio | 2.61 | 2.50 |
| Quick Ratio | 1.91 | 1.54 |
| Debt / Equity | 0.00 | 0.38 |
Cash flow (trailing twelve months)
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$14.57M | -$653.46K |
| Capital Expenditures | -$36.00K | -$3.69M |
| Free Cash Flow | -$14.61M | -$835.02K |
| FCF Per Share | -$0.20 | -$0.02 |
Efficiency
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.26 | 0.59 |
| Inventory Turnover | 0.93 | 2.21 |
| Revenue Per Employee | $50.43K | $322.57K |
| Profits Per Employee | -$224.73K | -$51.88K |
| Employee Count | 67 | 185 |
Dividends and yields
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Earnings Yield | -19.1% | -6.91% |
| FCF Yield | -18.5% | -0.56% |
Shares
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Shares Outstanding | 73,122,300 | 44,856,700 |
| Shares Change (YoY) | 25.0% | 3.35% |
| Float | 35,119,100 | 37,097,900 |
| Shares Held by Insiders | 52.0% | 10.6% |
Scores
| Measure | IceCure Medical | Industry median |
|---|---|---|
| Graham Number | $0.82 | $34.37 |
| Graham Upside | -24.3% | -57.7% |
| Altman Z-Score | -5.02 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from IceCure Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.